LICENSE AGREEMENT between RVL Pharmaceuticals, Inc. and SANTEN PHARMACEUTICAL CO. LTD. Dated as of July 28, 2020License Agreement • July 31st, 2020 • Osmotica Pharmaceuticals PLC • Pharmaceutical preparations • New York
This License Agreement (this “Agreement”) is made and entered into effective as of July 28, 2020 (the “Effective Date”) by and between RVL Pharmaceuticals, Inc., a Delaware corporation (“RVL”) and Santen Pharmaceutical Co. Ltd., a Japanese corporation (“Licensee”). RVL and Licensee are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
